Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 3 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Newly proposed survival staging system for poorly differentiated thyroid cancer: a SEER-based study.
J Endocrinol Invest. 2023 May;46(5):947-955. doi: 10.1007/s40618-022-01958-5. Epub 2022 Dec 9.
J Endocrinol Invest. 2023.
PMID: 36484934
FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
Huang J, Sun W, Wang Z, Lv C, Zhang T, Zhang D, Dong W, Shao L, He L, Ji X, Zhang P, Zhang H.
Huang J, et al.
J Exp Clin Cancer Res. 2022 Jan 28;41(1):42. doi: 10.1186/s13046-022-02254-z.
J Exp Clin Cancer Res. 2022.
PMID: 35090515
Free PMC article.
Item in Clipboard
Identification and validation of a pyroptosis-related prognostic signature for thyroid cancer.
Wu P, Shi J, Sun W, Zhang H.
Wu P, et al.
Cancer Cell Int. 2021 Oct 9;21(1):523. doi: 10.1186/s12935-021-02231-0.
Cancer Cell Int. 2021.
PMID: 34627252
Free PMC article.
Item in Clipboard
An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors.
Wu P, Sun W, Zhang H.
Wu P, et al.
Cancer Immunol Immunother. 2022 Mar;71(3):747-759. doi: 10.1007/s00262-021-03020-4. Epub 2021 Aug 16.
Cancer Immunol Immunother. 2022.
PMID: 34398303
Free PMC article.
Item in Clipboard
Cite
Cite